Surprising Yeast Discovery May Lead to New Cancer Treatments

Surprising Yeast Discovery May Lead to New Cancer Treatments
Study: Ribosomes hibernate on mitochondria during cellular stress

The discovery, made by scientists at the University of Virginia School of Medicine and collaborators at EMBL in Germany, reveals a previously unknown adaptation that allows yeast cells to go dormant when nutrients are insufficient. This ability to hibernate during stress mirrors cancer cells’ behavior, which helps them survive nutrient shortages caused by unregulated cell proliferation. This insight could open new avenues in cancer treatments by targeting this survival mechanism.

According to Ahmad Jomaa, PhD, a researcher in the School of Medicine’s Department of Molecular Physiology and Biological Physics, the surprising findings could lead to innovative approaches in making cancer cells more vulnerable to starvation and thus more responsive to cancer treatments.

“Cells can take a break when things get tough by going into deep sleep in order to stay alive, then at a later point they seemingly just come back,” said Jomaa, part of UVA’s Center for Membrane and Cell Physiology. “That’s why we need to understand the basics of adaptation to starvation and how these cells become dormant to stay alive and avoid death.”

Surviving Stress
S. pombe is a type of yeast that has been used to make beer for generations. It is, nonetheless, an essential study tool for biologists because to its closeness to human cells. knowledge S. pombe allows us to have a deeper knowledge of fundamental biological processes in both normal and malignant cells.

Working with Simone Mattei, PhD, and colleagues at EMBL, Jomaa and his team discovered that when yeast cells go into hibernation to avoid stress, they wrap themselves in an unexpected blanket. The surfaces of these batteries, known as mitochondria, become coated with inactive ribosomes, the cellular machinery that normally produces proteins.

It remains a mystery why these inactive ribosomes attach themselves to the mitochondria. “There could be different explanations,” Mattei said. “A starved cell will eventually start digesting itself, so the ribosomes might be coating the mitochondria to protect them. They might also attach to trigger a signaling cascade inside the mitochondria.”

The researchers were able to visualize how the ribosomes attach to the mitochondria down to the molecular level using astonishingly powerful single-particle cryo-electron microscopy and cryo-electron tomography. They were surprised to discover that the ribosomes had attached themselves “upside down,” using a small subunit of their anatomy. This type of interaction had never been seen before and could help decipher the secret of how cells enter and wake up from dormancy. “We knew that cells will try to save energy and shut down their ribosomes, but we were not expecting them to attach in an up-side state on the mitochondria,” said Maciej Gluc, a graduate student in Jomaa’s lab and co-first author of a new scientific paper describing the discovery.

The new findings could have a significant impact on our knowledge of cancer. Cancer cells experience constant food shortages due to their unregulated proliferation, and they frequently enter dormancy, or “quiescence,” to survive and avoid detection by our immune systems. Understanding how they do this may lead to novel approaches to target cancer cells, improving patient outcomes and preventing relapses.

“For the next steps, we aim to understand not only how cells regulate entry into dormancy but also how they awaken from this deep sleep. For now, we will use yeast because it is much easier to manipulate. We are now also investigating this in cultured cancer cells, which is not an easy task,” Jomaa said.

“Ultimately, I hope that my group’s research will lay the foundation for discovering new markers to track dormant cancer cells. These cells are not easily detected in diagnostic settings, but we are hopeful that our research will generate more interest in helping us reach our goal.”

Ahmad Jomaa, PhD, Researcher, Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine

UVA Cancer Center, one of only 57 “comprehensive” cancer centers designated by the National Cancer Institute, is dedicated to better understanding cancer and developing breakthrough treatments. The award honors cancer centers with the best cancer research and treatment programs in the country.

Findings published
The researchers reported their findings in the scholarly journal Nature Communications. The research team included Olivier Gemin, Gluc, Michael Purdy, Higor Rosa, Moritz Niemann, Yelena Peskova, Mattei, and Jomaa. The scientists have no financial interest in the project.

The research was funded by the Searle Scholars Program, the American Cancer Society, UVA’s Department of Molecular Physiology and Biological Physics, and the European Molecular Biology Laboratory.

For more information: Ribosomes hibernate on mitochondria during cellular stress, Nature Communications, doi.org/10.1038/s41467-024-52911-4

Driven by a deep passion for healthcare, Haritha is a dedicated medical content writer with a knack for transforming complex concepts into accessible, engaging narratives. With extensive writing experience, she brings a unique blend of expertise and creativity to every piece, empowering readers with valuable insights into the world of medicine.

more recommended stories